Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Erin K. Crane"'
Autor:
Bobbie J. Rimel, Erin K. Crane, June Hou, John Nakayama, Jennifer MacDonald, Kathleen Lutz, Vicky Makker, Roisin E. O'Cearbhaill
Publikováno v:
Gynecologic Oncology. 174:148-156
Autor:
Anil K. Sood, Keith A. Baggerly, Wei Hu, Cristina Ivan, Bulent Ozpolat, Gabriel Lopez-Berestein, Rajesha Rupaimoole, Sherry Y. Wu, Heather J. Dalton, Jamie Guenthoer, Robert L. Coleman, Erin K. Crane, Alpa M. Nick, Anna K. Unruh, Shelley M. Herbrich, Kshipra Gharpure, Susan L. Tucker
Purpose: Residual disease following primary cytoreduction is associated with adverse overall survival in patients with epithelial ovarian cancer. Accurate identification of patients at high risk of residual disease has been elusive, lacking external
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46533f3ff2d0b09961ba4518cdc7a35b
https://doi.org/10.1158/1078-0432.c.6523682.v1
https://doi.org/10.1158/1078-0432.c.6523682.v1
Autor:
Anil K. Sood, Keith A. Baggerly, Wei Hu, Cristina Ivan, Bulent Ozpolat, Gabriel Lopez-Berestein, Rajesha Rupaimoole, Sherry Y. Wu, Heather J. Dalton, Jamie Guenthoer, Robert L. Coleman, Erin K. Crane, Alpa M. Nick, Anna K. Unruh, Shelley M. Herbrich, Kshipra Gharpure, Susan L. Tucker
PDF file - 2766KB, Supplementary methods and reports describing all data analyses. Supplementary Table 1. Probesets (N=47) and associated genes (N=38) having consistent differences in expression between residual disease (RD) and No-RD patients in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a49e1975bfd9ffd55f06a963712a72
https://doi.org/10.1158/1078-0432.22457747.v1
https://doi.org/10.1158/1078-0432.22457747.v1
Autor:
R. Wendel Naumann, Erin V. Kemp, David L. Tait, Alanna Lehman, Sophia N Brancazio, Jubilee Brown, Erin K. Crane, Valerie D. Taylor
Publikováno v:
Journal of Minimally Invasive Gynecology. 29:114-118
STUDY OBJECTIVE To identify factors associated with same day discharge (SDD) after laparoscopic surgery in gynecologic oncology. DESIGN Retrospective cohort. SETTING Teaching hospital. PATIENTS Total of 800 patients having minimally invasive surgery
Autor:
Matthew A. Powell, Erin K. Crane, Sean C. Dowdy, Alexander Shushkevich, Douglas A. Levine, Brian M. Slomovitz, Michael D. Toboni, Jubilee Brown, Sarah Chiang, Premal H. Thaker, Ann H. Klopp
Publikováno v:
Gynecologic Oncology. 162:235-241
Objective Uterine carcinosarcoma (UCS) is a rare but aggressive cancer. In early-stage disease data guiding treatment is sparse. The purpose of this review is to summarize the findings from the 2019 NRG oncology group summer symposium meeting as well
Autor:
Erin V. Kemp, Valerie D. Taylor, Alanna Lehman, R. Wendel Naumann, David L. Tait, Jubilee Brown, Erin K. Crane
Publikováno v:
Journal of Minimally Invasive Gynecology. 28:811-816
STUDY OBJECTIVE To review the impact of enhanced recovery after surgery (ERAS) after minimally invasive surgery (MIS) with respect to perioperative narcotics, time in the recovery room, and total time in hospital. DESIGN Retrospective cohort. SETTING
Autor:
Khrystyna Levytska, Ziqing Yu, Meghan Wally, Susan Odum, Joseph R. Hsu, Rachel Seymour, Jubilee Brown, Erin K. Crane, David L. Tait, Allison M. Puechl, Brittany Lees, R. Wendel Naumann, Michael Beuhler, Michael J. Bosse, Michael Gibbs, Christopher Griggs, Ashu Gulati, Steven Jarrett, Daniel Leas, Tamar Roomian, Michael Runyon, Animita Saha, D. Matthew Sullivan, Brad Watling
Publikováno v:
Gynecologic oncology. 166(3)
Enhanced recovery after surgery (ERAS) has decreased hospital opioid use, but less attention has been directed towards its impact on clinic burden with respect to post-operative care. Our objective was to determine the impact of an ERAS protocol on p
Autor:
Erin K. Crane, Charles F. Levenback
Publikováno v:
Clinical Lymphatic Mapping in Gynecologic Cancers ISBN: 9781003255536
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ae94c73ecd5696491b558e1dfb6ab1f
https://doi.org/10.1201/9781003255536-2
https://doi.org/10.1201/9781003255536-2
Autor:
Linda R. Duska, Katherine M. Moxley, Sarah M. Temkin, Julie K. Schwarz, Sheena H. Clift, Chad A. Hamilton, Timothy N. Showalter, Timothy N. J. Bullock, Jennifer Scalici, Gina R. Petroni, Stephanie L. Wethington, Erin K. Crane, Nikole Varhegyi
Publikováno v:
Cancer. 126:4948-4956
Background Immune checkpoint inhibitors are being considered for locally advanced cervical cancer (LACC) together with standard-of-care pelvic chemoradiation (CRT). However, the safety of the combination and its optimal schedule are unknown. Defining
Autor:
Erin K Crane, Suet-Yan Kwan, Daisy I Izaguirre, Yvonne T M Tsang, Lisa K Mullany, Zhifei Zu, JoAnne S Richards, David M Gershenson, Kwong-Kwok Wong
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135101 (2015)
Epithelial ovarian cancer is a diverse molecular and clinical disease, yet standard treatment is the same for all subtypes. TP53 mutations represent a node of divergence in epithelial ovarian cancer histologic subtypes and may represent a therapeutic
Externí odkaz:
https://doaj.org/article/9e23d34016db45179dfd7383e8ef59d5